Generic Name and Formulations:
Ganciclovir 0.15%; ophthalmic gel; contains benzalkonium chloride.
Bausch & Lomb Inc.
Indications for ZIRGAN:
Acute herpetic keratitis (dendritic ulcers).
Adults and Children:
<2yrs: not recommended. ≥2yrs: 1 drop in the affected eye(s) 5 times daily (every 3 hours while awake) until corneal ulcer heals, then 1 drop 3 times daily for 7 days.
Remove contact lenses during therapy. Pregnancy (Cat.C). Nursing mothers.
Blurred vision, eye irritation, punctate keratitis, conjunctival hyperemia.
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Tools to Address the Opioid Crisis
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation
- FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
- Central Sensitization in Greater Trochanteric Pain Syndrome
- Pain Acceptance May Reduce Headache-Related Disability in Migraine
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds